NCT05008835

Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 61 (actual)
• Sponsor: ACADIA Pharmaceuticals Inc. · Industry
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the efficacy of ACP-044 compared with placebo in the treatment of pain associated with osteoarthritis of the knee

Conditions

• Osteoarthritis Pain

Interventions

Type	Name	Description
DRUG	ACP-044 Dose A	Oral dose of ACP-044 Dose A
DRUG	ACP-044 Dose B	Oral dose of ACP-044 Dose B
DRUG	Placebo	Placebo

Timeline

• Start date: 2021-07-20
• Primary completion: 2022-10-06
• Completion: 2022-11-16
• First posted: 2021-08-17
• Last updated: 2025-01-09
• Results posted: 2025-01-09

Locations

34 sites across 1 country: United States

Regulatory

• FDA-regulated drug study